UK Blood-based Biomaker For Sports Medicine Market Size & Outlook
UK blood-based biomaker for sports medicine market, 2018-2030 (US$M)
Related Markets
UK blood-based biomaker for sports medicine market highlights
- The UK blood-based biomaker for sports medicine market generated a revenue of USD 32.5 million in 2023 and is expected to reach USD 62.1 million by 2030.
- The UK market is expected to grow at a CAGR of 9.7% from 2024 to 2030.
- In terms of segment, ck was the largest revenue generating type in 2023.
- CRP is the most lucrative type segment registering the fastest growth during the forecast period.
Blood-based biomaker for sports medicine market data book summary
| Market revenue in 2023 | USD 32.5 million |
| Market revenue in 2030 | USD 62.1 million |
| Growth rate | 9.7% (CAGR from 2023 to 2030) |
| Largest segment | Ck |
| Fastest growing segment | CRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6 |
Other key industry trends
- In terms of revenue, UK accounted for 4.9% of the global blood-based biomaker for sports medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood-based biomaker for sports medicine market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 86.6 million by 2030.
Ck was the largest segment with a revenue share of 17.85% in 2023. Horizon Databook has segmented the UK blood-based biomaker for sports medicine market based on ck, myoglobin, lactate, wbc, urea, crp, lipid and protein hydroperoxides, il-6 covering the revenue growth of each sub-segment from 2018 to 2030.
In the UK, this rising incidence of sports-related injuries is expected to drive significant growth in the market for blood-based biomarkers for sports medicine. A 2023 study conducted in England and Wales reported an overall annual sports injury incidence rate of 5.40 injuries per 100,000 participants. The data highlights that men experienced a higher incidence rate at 6.44 per 100,000 compared to women at 3.34 per 100,000.
Among different activities, sports had the highest incidence rate at 9.88 per 100,000, significantly surpassing cycling (2.81 per 100,000), fitness (0.21 per 100,000), or walking (0.03 per 100,000). Specific activities showed even higher rates, with motorsports at 532.31 per 100,000, equestrian sports at 235.28 per 100,000, and gliding at 190.81 per 100,000.
As the demand for more precise and efficient injury management solutions grows, the UK market is expected to witness rapid growth, reflecting broader trends in athlete care and injury prevention.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood-based Biomaker for Sports Medicine Market Scope
Blood-based Biomaker for Sports Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK blood-based biomaker for sports medicine market size, by type, 2018-2030 (US$M)
UK Blood-based Biomaker for Sports Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
